Literature DB >> 12060697

Unmodified Cre recombinase crosses the membrane.

Elke Will1, Hannes Klump, Nicole Heffner, Maike Schwieger, Bernhard Schiedlmeier, Wolfram Ostertag, Christopher Baum, Carol Stocking.   

Abstract

Site-specific recombination in genetically modified cells can be achieved by the activity of Cre recombinase from bacteriophage P1. Commonly an expression vector encoding Cre is introduced into cells; however, this can lead to undesired side-effects. Therefore, we tested whether cell-permeable Cre fusion proteins can be directly used for lox-specific recombination in a cell line tailored to shift from red to green fluorescence after loxP-specific recombination. Comparison of purified recombinant Cre proteins with and without a heterologous 'protein transduction domain' surprisingly showed that the unmodified Cre recombinase already possesses an intrinsic ability to cross the membrane border. Addition of purified recombinant Cre enyzme to primary bone marrow cells isolated from transgenic C/EBPalpha(fl/fl) mice also led to excision of the 'floxed' C/EBPalpha gene, thus demonstrating its potential for in vivo applications. We conclude that Cre enyzme itself or its intrinsic membrane-permeating moiety are attractive tools for direct manipulation of mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060697      PMCID: PMC117301          DOI: 10.1093/nar/gnf059

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  Creating a transloxation. Engineering interchromosomal translocations in the mouse.

Authors:  G Testa; A F Stewart
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

2.  Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens.

Authors:  S Oess; E Hildt
Journal:  Gene Ther       Date:  2000-05       Impact factor: 5.250

3.  Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Authors:  M Hildinger; K L Abel; W Ostertag; C Baum
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

Authors:  A Loonstra; M Vooijs; H B Beverloo; B A Allak; E van Drunen; R Kanaar; A Berns; J Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity.

Authors:  D P Silver; D M Livingston
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

6.  Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase.

Authors:  D Jo; A Nashabi; C Doxsee; Q Lin; D Unutmaz; J Chen; H E Ruley
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

7.  Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes.

Authors:  Michael Peitz; Kurt Pfannkuche; Klaus Rajewsky; Frank Edenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

8.  Functional identification of secondary mutations inducing autonomous growth in synergy with a truncated interleukin-3 receptor: implications for multi-step oncogenesis.

Authors:  V Prassolov; J Meyer; G Brandenburg; J Hannemann; J Bergemann; W Ostertag; C Stocking
Journal:  Exp Hematol       Date:  2001-06       Impact factor: 3.084

9.  Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy.

Authors:  H Klump; B Schiedlmeier; B Vogt; M Ryan; W Ostertag; C Baum
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

10.  Vectors for the inducible overexpression of glutathione S-transferase fusion proteins in yeast.

Authors:  D A Mitchell; T K Marshall; R J Deschenes
Journal:  Yeast       Date:  1993-07       Impact factor: 3.239

View more
  20 in total

1.  Cellular restriction of retrovirus particle-mediated mRNA transfer.

Authors:  Melanie Galla; Axel Schambach; Greg J Towers; Christopher Baum
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 2.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

3.  Delivery of antibodies to the cytosol: debunking the myths.

Authors:  Andrea L J Marschall; Congcong Zhang; André Frenzel; Thomas Schirrmann; Michael Hust; Franck Perez; Stefan Dübel
Journal:  MAbs       Date:  2014-05-21       Impact factor: 5.857

4.  PVX-Cre-mediated marker gene elimination from transgenic plants.

Authors:  L Kopertekh; G Jüttner; J Schiemann
Journal:  Plant Mol Biol       Date:  2004-07       Impact factor: 4.076

5.  The pollen- and embryo-specific Arabidopsis DLL promoter bears good potential for application in marker-free Cre/loxP self-excision strategy.

Authors:  Zuzana Polóniová; Martin Jopčík; Ildikó Matušíková; Jana Libantová; Jana Moravčíková
Journal:  Plant Cell Rep       Date:  2014-12-13       Impact factor: 4.570

6.  Bone marrow cells adopt the cardiomyogenic fate in vivo.

Authors:  Marcello Rota; Jan Kajstura; Toru Hosoda; Claudia Bearzi; Serena Vitale; Grazia Esposito; Grazia Iaffaldano; M Elena Padin-Iruegas; Arantxa Gonzalez; Roberto Rizzi; Narissa Small; John Muraski; Roberto Alvarez; Xiongwen Chen; Konrad Urbanek; Roberto Bolli; Steven R Houser; Annarosa Leri; Mark A Sussman; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

7.  Mesoporous silica nanoparticle-mediated intracellular cre protein delivery for maize genome editing via loxP site excision.

Authors:  Susana Martin-Ortigosa; David J Peterson; Justin S Valenstein; Victor S-Y Lin; Brian G Trewyn; L Alexander Lyznik; Kan Wang
Journal:  Plant Physiol       Date:  2013-12-27       Impact factor: 8.340

8.  Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase.

Authors:  Lakshmikanth Mariyanna; Poornima Priyadarshini; Helga Hofmann-Sieber; Marcel Krepstakies; Nicole Walz; Adam Grundhoff; Frank Buchholz; Eberhard Hildt; Joachim Hauber
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

9.  Monodispersity of recombinant Cre recombinase correlates with its effectiveness in vivo.

Authors:  Paola Capasso; Marisa Aliprandi; Giuseppe Ossolengo; Frank Edenhofer; Ario de Marco
Journal:  BMC Biotechnol       Date:  2009-09-11       Impact factor: 2.563

Review 10.  Less is more: strategies to remove marker genes from transgenic plants.

Authors:  Yuan-Yeu Yau; C Neal Stewart
Journal:  BMC Biotechnol       Date:  2013-04-23       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.